行为復健市场－全球产业规模、份额、趋势、机会和预测，按行为障碍类型、医疗环境、治疗方法、地区和竞争细分，2020 年至 2030 年

2024年，全球行为復健市场规模达2,254.2亿美元，预计在预测期内将显着成长，到2030年复合年增长率将达到6.07%。行为復健是一种心理治疗技术，用于解决对个人健康构成威胁的特定习得行为。此方法涵盖咨商、药物治疗以及一系列支援服务，包括强化、惩罚和榜样示范。其目的是改变个人的心理状态，减少自我毁灭和不健康行为的发生。透过辨识和解决与易怒、不当行为、药物滥用、忧郁、焦虑、衝动、攻击性、过动和悲伤相关的模式，行为復健为个人提供有效的策略来管理自己的情绪和行为，治疗人格、情绪和注意力不足过动症。行为復健涉及后天性脑损伤的后期治疗，特别着重于应对患者情绪状态的变化。这种治疗形式可以帮助患者获得有效管理不当行为的技能，这些行为可能会对家人、同事、朋友和其他人造成困扰。行为復健可以有效解决诸如易怒、情绪波动、情绪不稳定以及参与不当行为等症状。

关键市场驱动因素

精神健康障碍盛行率上升

主要市场挑战

缺乏患者登记

主要市场趋势

越来越多的数位戒毒项目

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球行为復健市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依行为障碍类型（焦虑症、情绪障碍、物质滥用障碍、人格障碍和注意力缺陷障碍）
  • 依医疗环境（门诊行为復健、住院行为復健和住宅行为復健）
  • 依治疗方法（咨询、药物、支持服务和其他治疗方法）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美行为復健市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲行为復健市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太行为康復市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲行为復健市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲行为復健市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Allergan, Inc.
• Novartis AG
• Taro Pharmaceutical Industries
• Perrigo Company plc
• Zynerba Pharmaceuticals
• Apotex Inc.
• Sandoz AG
• Strides Arcolab Ltd.
• TOLMAR Pharmaceuticals, Inc.
• Limbix Health Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

Global Behavioural Rehabilitation Market was valued at USD 225.42 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.07% through 2030. Behavioral rehabilitation is a psychotherapeutic technique employed to address specific learned behaviors that pose a threat to an individual's well-being. This approach encompasses counseling, medication, and a range of support services, including reinforcement, punishment, and modeling. Its aim is to modify an individual's psychological conditioning, reducing the occurrence of self-destructive and unhealthy behaviors. By identifying and addressing patterns associated with irritability, inappropriate actions, substance abuse, depression, anxiety, impulsivity, aggression, hyperactivity, and grief, behavioral rehabilitation equips individuals with effective strategies to manage their emotions and actions, treating personality, mood, and attention deficit disorders. Behavioral rehabilitation pertains to the post-treatment of acquired brain injuries, with a specific focus on addressing changes in the patient's emotional state. This form of treatment aids patients in acquiring skills to effectively manage inappropriate actions that may pose challenges to their family members, co-workers, friends, and others. Symptomatic manifestations such as increased irritability, mood swings, emotional lability, and engaging in inappropriate behaviors are among the issues that can be effectively addressed through behavioral rehabilitation.

Key Market Drivers

Increase in the Prevalence of Mental Health Disorders

The rise in the prevalence of mental health disorders worldwide serves as a significant driver for the growth of the behavioral rehabilitation market. For instance, according to the NIH, over one in five U.S. adults-approximately 59.3 million people or 23.1% of the adult population-were living with a mental illness in 2022. This statistic highlights the widespread impact of mental health conditions across the country and underscores the urgent need for accessible, effective mental health services and support systems to address the growing demand for care. The emergence of various internet interventions for treating common mental disorders, particularly in remote patient monitoring and easy accessibility, along with the widespread adoption of cost-effective online counseling sessions, contribute to the accelerated market growth. For instance, in September 2023, Praesum Healthcare Services, LLC acquired Beacon Point Recovery Center, LLC, a behavioral health provider network based in Philadelphia, U.S. The acquisition aims to expand Praesum's footprint in the behavioral health sector and enhance access to quality mental health and addiction treatment services in the region. The increasing prevalence of anxiety, dementia, depression, and other psychological disorders among the population is a key driver for market growth. The growing preference for partial hospitalization programs (PHPs) among patients is bolstering market expansion. These multi-day programs, offered by rehabilitation centers and hospitals, aim to facilitate emotional regulation, conflict resolution, anger management, and substance abuse treatment. In line with this, various government and non-government organizations also organize camps to provide behavioral rehabilitation for individuals with post-traumatic stress disorder (PTSD) and drug addiction, thereby contributing to market growth. The availability of online counseling services acts as another growth-inducing factor. With the onset of the Covid-19 pandemic, individuals are increasingly adopting online platforms to access timely treatment and recovery support.

Key Market Challenges

Lack of Patient Enrollment

The lack of patient enrollment hinders the growth of behavioral rehabilitation programs. Patient enrollment refers to the process of recruiting and enrolling individuals into these programs for treatment and intervention. This challenge can impact the effectiveness, reach, and sustainability of behavioral rehabilitation efforts. Low patient enrollment can result in a limited number of individuals accessing behavioral rehabilitation services. This restricts the availability of treatment options for those in need and can contribute to unmet mental health and behavioral health needs. Behavioral rehabilitation programs often require significant resources, including trained professionals, facilities, and support staff. A lack of patient enrollment means that these resources might be underutilized, leading to inefficiencies and decreased cost-effectiveness. Many behavioral rehabilitation programs rely on patient fees, insurance reimbursements, or government funding to operate. A lack of patient enrollment can strain the financial sustainability of programs, potentially leading to reduced services or closure.

Key Market Trends

Increasing Number of Digital Detoxification Programs

The growing prevalence of digital detoxification programs is a significant driver of market growth in the behavioral rehabilitation sector. Internet and social media addictions have seen a surge due to global technological advancements, impacting individuals, particularly teenagers and young adults who are tech-savvy. Digital detox programs play a crucial role in addressing internet addiction, with the Chinese government taking the lead in implementing boot camps specifically targeting young adults. The focus on digital detoxification programs in Asia is expected to prompt other countries worldwide to follow suit, resulting in an increased number of digital rehabilitation programs and driving market growth throughout the forecast period.

Key Market Players

Allergan, Inc.

Novartis AG

Taro Pharmaceutical Industries

Perrigo Company plc

Zynerba Pharmaceuticals

Apotex Inc.

Sandoz AG

Strides Arcolab Ltd.

TOLMAR Pharmaceuticals, Inc.

Limbix Health Inc

Report Scope:

In this report, the Global Behavioural Rehabilitation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Behavioural Rehabilitation Market, By Type of Behavioural Disorder:

• Anxiety Disorder
• Mood Disorder
• Substance Abuse Disorder
• Personality Disorder
• Attention Deficit Disorder

Behavioural Rehabilitation Market, By Healthcare Setting:

• Outpatient Behavioural Rehabilitation
• Inpatient Behavioural Rehabilitation
• Residential Behavioural Rehabilitation

Behavioural Rehabilitation Market, By Treatment Method:

• Counselling
• Medication
• Support Services
• Other Treatment Methods

Behavioural Rehabilitation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Behavioural Rehabilitation Market.

Available Customizations:

Global Behavioural Rehabilitation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Behavioural Rehabilitation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Behavioural Disorder (Anxiety Disorder, Mood Disorder, Substance Abuse Disorder, Personality Disorder, and Attention Deficit Disorder)
  • 5.2.2. By Healthcare Setting (Outpatient Behavioural Rehabilitation, Inpatient Behavioural Rehabilitation, and Residential Behavioural Rehabilitation)
  • 5.2.3. By Treatment Method (Counselling, Medication, Support Services, and Other Treatment Methods)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Behavioural Rehabilitation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Behavioural Disorder
  • 6.2.2. By Healthcare Setting
  • 6.2.3. By Treatment Method
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Behavioural Rehabilitation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Behavioural Disorder
      • 6.3.1.2.2. By Healthcare Setting
      • 6.3.1.2.3. By Treatment Method
  • 6.3.2. Canada Behavioural Rehabilitation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Behavioural Disorder
      • 6.3.2.2.2. By Healthcare Setting
      • 6.3.2.2.3. By Treatment Method
  • 6.3.3. Mexico Behavioural Rehabilitation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Behavioural Disorder
      • 6.3.3.2.2. By Healthcare Setting
      • 6.3.3.2.3. By Treatment Method

7. Europe Behavioural Rehabilitation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Behavioural Disorder
  • 7.2.2. By Healthcare Setting
  • 7.2.3. By Treatment Method
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Behavioural Rehabilitation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Behavioural Disorder
      • 7.3.1.2.2. By Healthcare Setting
      • 7.3.1.2.3. By Treatment Method
  • 7.3.2. United Kingdom Behavioural Rehabilitation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Behavioural Disorder
      • 7.3.2.2.2. By Healthcare Setting
      • 7.3.2.2.3. By Treatment Method
  • 7.3.3. Italy Behavioural Rehabilitation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Behavioural Disorder
      • 7.3.3.2.2. By Healthcare Setting
      • 7.3.3.2.3. By Treatment Method
  • 7.3.4. France Behavioural Rehabilitation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Behavioural Disorder
      • 7.3.4.2.2. By Healthcare Setting
      • 7.3.4.2.3. By Treatment Method
  • 7.3.5. Spain Behavioural Rehabilitation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Behavioural Disorder
      • 7.3.5.2.2. By Healthcare Setting
      • 7.3.5.2.3. By Treatment Method

8. Asia-Pacific Behavioural Rehabilitation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Behavioural Disorder
  • 8.2.2. By Healthcare Setting
  • 8.2.3. By Treatment Method
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Behavioural Rehabilitation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Behavioural Disorder
      • 8.3.1.2.2. By Healthcare Setting
      • 8.3.1.2.3. By Treatment Method
  • 8.3.2. India Behavioural Rehabilitation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Behavioural Disorder
      • 8.3.2.2.2. By Healthcare Setting
      • 8.3.2.2.3. By Treatment Method
  • 8.3.3. Japan Behavioural Rehabilitation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Behavioural Disorder
      • 8.3.3.2.2. By Healthcare Setting
      • 8.3.3.2.3. By Treatment Method
  • 8.3.4. South Korea Behavioural Rehabilitation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Behavioural Disorder
      • 8.3.4.2.2. By Healthcare Setting
      • 8.3.4.2.3. By Treatment Method
  • 8.3.5. Australia Behavioural Rehabilitation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Behavioural Disorder
      • 8.3.5.2.2. By Healthcare Setting
      • 8.3.5.2.3. By Treatment Method

9. South America Behavioural Rehabilitation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Behavioural Disorder
  • 9.2.2. By Healthcare Setting
  • 9.2.3. By Treatment Method
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Behavioural Rehabilitation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Behavioural Disorder
      • 9.3.1.2.2. By Healthcare Setting
      • 9.3.1.2.3. By Treatment Method
  • 9.3.2. Argentina Behavioural Rehabilitation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Behavioural Disorder
      • 9.3.2.2.2. By Healthcare Setting
      • 9.3.2.2.3. By Treatment Method
  • 9.3.3. Colombia Behavioural Rehabilitation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Behavioural Disorder
      • 9.3.3.2.2. By Healthcare Setting
      • 9.3.3.2.3. By Treatment Method

10. Middle East and Africa Behavioural Rehabilitation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Behavioural Disorder
  • 10.2.2. By Healthcare Setting
  • 10.2.3. By Treatment Method
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Behavioural Rehabilitation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Behavioural Disorder
      • 10.3.1.2.2. By Healthcare Setting
      • 10.3.1.2.3. By Treatment Method
  • 10.3.2. Saudi Arabia Behavioural Rehabilitation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Behavioural Disorder
      • 10.3.2.2.2. By Healthcare Setting
      • 10.3.2.2.3. By Treatment Method
  • 10.3.3. UAE Behavioural Rehabilitation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Behavioural Disorder
      • 10.3.3.2.2. By Healthcare Setting
      • 10.3.3.2.3. By Treatment Method

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Allergan, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Novartis AG
• 14.3. Taro Pharmaceutical Industries
• 14.4. Perrigo Company plc
• 14.5. Zynerba Pharmaceuticals
• 14.6. Apotex Inc.
• 14.7. Sandoz AG
• 14.8. Strides Arcolab Ltd.
• 14.9. TOLMAR Pharmaceuticals, Inc.
• 14.10. Limbix Health Inc.

15. Strategic Recommendations

16. About Us & Disclaimer